Search for the latest updates on cancer
News
Heat Biologics Commences Dosing of First Patient in Phase 1/2 Study of Novel Cancer Immunotherapy Product Candidate HS ... Marketwired via Yahoo! Finance - 58 minutes
CHAPEL HILL, NC--(Marketwired - Mar 3, 2014) - Heat Biologics, Inc. (NASDAQ: HTBX), a clinical stage biopharmaceutical company focused on the ...
Manage alerts · Unsubscribe · Privacy Policy
Tip: To exclude words, type - (hyphen or dash for minus) in front of each word that cannot be in the search results.(blackberries health -device)
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment